It is exciting to be a part of the incredible transformation underway in the healthcare sector and I work passionately to help clients achieve exceptional results.
Michael is a member of Lincoln’s Healthcare Group and leads the firm’s Healthcare Information Technology (HCIT) practice. He advises private equity clients, publicly traded companies and privately held businesses on mergers and acquisitions, as well as equity and debt capital raises. With close to two decades of experience in the industry, Michael has developed deep domain expertise and strong industry relationships across the sector. Michael has completed over 40 transactions in the healthcare sector for some of the most prominent companies in the industry.
The Healthcare sector is rapidly evolving as the adoption of technology such as software, data and analytics seek to improve patient outcomes while reducing overall cost and complexity. Michael’s understanding of the healthcare continuum, and how all constituents, patients, providers, payors and life sciences businesses are embracing technology, leads to exceptional outcomes for his clients.
Prior to joining Lincoln, Michael was at Houlihan Lokey where he helped lead the firm’s Healthcare Information Technology team. Previously, Michael worked as a Director at Deutsche Bank in the Healthcare Investment Banking group.
Michael earned a Bachelor of Science in finance from Villanova University.
Recent Transactions in Healthcare
Lincoln International advised Apposite Capital and worked closely with the MC Care team throughout the transaction
Lincoln International is pleased to announce MedTest Holdings, a portfolio company of Enhanced Healthcare Partners, has been sold to HORIBA
Lincoln International advised Thomas H. Lee Partners on the sale of Healthcare Staffing Services to Cornell Capital
Lincoln International is pleased to announce that Homedical Atenção Domiciliar received a strategic investment from Crescera Capital, a leading Brazilian private equity fund
Lincoln International served as the exclusive financial advisor and debt arranger to OrthoFi on its acquisition of OrthoBanc
Lincoln International is pleased to have advised AnGes, Inc. on its acquisition of EmendoBio, Inc., a leader in next-generation novel nuclease discovery and gene editing technologies, at a valuation of $250 million
Perspectives featuring Michael Siano
Interim/Post-COVID-19 Sector Outlook: Services & Products for Homebound Patients
Click the home healthcare sectors below to view key takeaways on the effects of COVID-19. Medical and Personal Services Skilled Home Healthcare Near term: REASONABLY STABLE / POSITIVE Long term:… Read More
COVID-19 Pandemic Could Accelerate Recent U.S. Healthcare Growth Trends
One hundred years after the 1918 Spanish Flu, the world is facing another pandemic: COVID-19. Government and healthcare officials are working around the clock to flatten the curve and slow… Read More
Q&A: Identifying the Non-Cyclical Sectors Most Resistant to a Potential Recession
Original post from Pitchbook on December 5, 2019 here. … Read More